Global drug discovery informatics market is anticipated to reach
USD 6,548.1 million by 2022, according to a new report by Grand View Research
Inc.Ongoing improvement incomputational technology is anticipated to drive the
adoption of in-silicotherapeutic product discovery models thus,
influencing sectorprogress over the forecast period.
Drug discovery informatics industry is estimated to witness
lucrative growth over the forecast period majorly due to, the rising number of
technologically advanced products in the field of drug development. Significant
shift observed from traditional in-vitro drug developmentto computer
aided drug designing, as costly failures of late drug development increases the
use of in-silico models for early ADME/Toxicity screening is anticipated
to propel progress in this sector.
Furthermore, R&D carried out in the field of information
technology for the facilitation of analytics and visualization applications
that enable data aggregation and processing is attributive for driving growth
in this market through to 2022.
Request to Sample
of This Report @ http://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market
Further key findings from the report suggest:
- Discovery informatics dominated accounting for the largest share of the market in 2014 owing to presence of substantial number of in-silico tools and databases in this segment, which aid the process of lead identification and validation.
- Development informatics is anticipated to witness substantial progress in the coming years because of upcoming development in the sub segments that involve clinical trial data management services and softwares.
- As per the mode of informatics solutions, outsourced informatics accounted for a large share in 2014 because of the high capital costs associated with in-house services for drug discovery IT solutions. Furthermore, with the rise in collaborations andlead compound discovery projects between IT market participants and pharmaceutical companies, outsourcedservicesare expected to continue to register lucrative demand in the coming years.
- Sequence analysis based informatics was the largest service segmentin 2014 and is expected to maintain its dominance through to 2022. High R&D investment for genomic sequencing as this being the initial step for target as well as lead identification is expected to support in projected progress.Moreover, enhancement in NGS technology coupled with growing adoption rate due to reduction in cost of sequencing per base pairare prime factors responsible in driving demand for NGS sequence analysis technology solutions thus impacting segment growth positively.
- North America accounted for the largest share of revenue generated in 2014. This large share can be accounted for by the presence of an enhanced technological framework, high R&D investment in information technology; growing adoption of computational novel entities discovery paradigms are the major factors attributive for region’s dominant market position.
- However, Asia Pacific is projected to register the fastest growth over the forecast period owing to technological developments carried out in the developing economies of this region in order to promote introduction of novel drug targets and chemical entities for reduction of chronic disease burden
- Key players operating in this market includeGVK Biosciences, Boehringer Ingelheim GmBh, Albany Molecular Research Inc, Certara, Infosys, DiscoverX, Selvita, Jubilant Biosys, Collaborative Drug Discovery Inc., Charles River Laboratories, ChemAxon, and Novo Informatics.
- These entities are involved in collaborations with therapeutic product discovery and development laboratories, clinical research organizations, academic institutes, pharmaceutical companies, and clinical research institutes in order to gain access in the competitive industry.
To Get Sample Copy of Report visit
@ http://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market/request
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For More Information,
Visit Grand
View Research
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment